Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study

Both angiotensin-receptor blockers (ARB) and angiotensin-converting enzyme inhibitors (ACEI) have protective effects against atrial fibrillation (AF). The differences between ARB and ACEI in their effects on the primary prevention of AF remain unclear. This study compared ARB and ACEI in combined an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yu-Cheng, Hung, Chen-Ying, Li, Cheng-Hung, Liao, Ying-Chieh, Huang, Jin-Long, Lin, Ching-Heng, Wu, Tsu-Juey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902433/
https://www.ncbi.nlm.nih.gov/pubmed/27196491
http://dx.doi.org/10.1097/MD.0000000000003721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902433/
https://www.ncbi.nlm.nih.gov/pubmed/27196491
http://dx.doi.org/10.1097/MD.0000000000003721

Ejemplares similares